Patent ID: 9320742
Filing Date: 2016-04-26
CPC Classification: A61K,A61P

Claim Text:
1. A transdermal drug delivery system comprising a drug-containing layer defining an active surface area and comprising a polymer matrix comprising about 20% by weight acrylic adhesive, about 59% by weight silicone adhesive, about 12% by weight soluble polyvinylpyrrolidone (PVP), about 6% by weight oleyl alcohol, and about 2-3% by weight testosterone, all based on the total dry weight of the polymer matrix, wherein the system includes less than 0.3 mg/cm 2 testosterone, and achieves a testosterone flux that is at least 0.7 μg/cm 2 /hour, based on the active surface area, wherein the polymer matrix comprises an amount of testosterone effective to deliver an amount of testosterone from about 100 to about 500 μg/day.